Search
for
Sort by
Research 511–540 of 1000+
- 5-Alpha reductase deficiency
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Local and Systemic Reduction by Topical Finasteride or Flutamide of Hamster Flank Organ Size and Enzyme Activity
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Interventions for female pattern hair loss
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Prevalence of Hyperandrogenic States in Late Adolescent and Young Women: Epidemiological Survey on Italian High-School Students
- Pharmacotherapy of polycystic ovary syndrome - an update
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Madarosis
- Cutaneous Manifestations of Eating Disorders
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Gender-Affirming Hormone Therapy for Transgender Females
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Contemporary medical therapy for polycystic ovary syndrome
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance
- Nonclassic congenital adrenal hyperplasia